Literature DB >> 9290790

Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.

Z Ben-Ari1, D Shmueli, E Mor, E Shaharabani, N Bar-Nathan, Z Shapira, R Tur-Kaspa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9290790     DOI： 10.1016/s0041-1345(97)00556-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.

Authors:  W E Delaney; T G Miller; H C Isom
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Orthotopic liver transplantation for fulminant hepatitis B.

Authors:  Xiao-Shun He; Jie-Fu Huang; Gui-Hua Chen; Qian Fu; Xiao-Feng Zhu; Min-Qiang Lu; Guo-Dong Wang; Xiang-Dong Guan
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

3.  Hepatitis B.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

Review 4.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

5.  Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.

Authors:  Kathie-Anne Walters; Graham A Tipples; Marchelle I Allen; Lynn D Condreay; William R Addison; Lorne Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.